CHICAGO (Reuters) - The estrogen-blocker Aromasin was found to reduce the risk of developing breast cancer by 65 percent in post-menopausal women at high risk for breast cancer, researchers said on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results